Drugs / Omega-3-acids ethylesters 90
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02035215 | Jan → Oct 2014 | familial hyperlipidemia | Kuhnil Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02305355 | Feb 2009 → Feb 2011 | hypertriglyceridemia, type 2 diabetes mellitus | Kuhnil Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omega-3-acids ethylesters 90 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02305355 ↗ |
| Route | Oral | “po, q.d” NCT02035215 ↗ |